Big effect
Taurine at 2 g/day after a liver transplant was tied to four fewer days in the ICU and a drop in mortality — but the trial tracked only 225 people in a very specific medical setting.
This is a striking result for a severely ill group, but it's the first RCT on taurine for post-transplant outcomes, so we can't yet say if the benefit extends to healthier people or even to other transplant patients.
Liver transplant recipients who took 2 g of taurine daily for a month saw better liver function markers and spent about four fewer days in intensive care and 3.5 fewer days in hospital. Mortality was also lower in the taurine group, but the study was small and looked only at people undergoing a major surgery, not the general population.
Where this fits in the evidence
This is among the first studies we've indexed on Taurine for Reduced Mortality Risk — treat it as an early signal until more research accumulates.
The study
- Randomized Controlled Trial (RCT)
- n = 225
- 2026-04
- Clinical nutrition ESPEN
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.